{"article_id": "IFF_q1_2021.txt", "article": ["we achieved 3 % in combined sales growth , or 1 % in currency - neutral basis , compared to the first quarter of 2020 .", "also because of our change to a fiscal calendar rather than a traditional 4 - 4 - 5 calendar , we have had less -- two days less in first quarter .", "if we were to normalize for that , our combined currency - neutral growth in the first quarter would also have been approximately 3 % .", "and on a two - year average basis , to factor in our strong 7 % year - ago comparison , growth would be strong at approximately 5 % .", "our adjusted operating ebitda margin improved by 30 basis points , reflecting our team 's diligent execution of our cost management strategy .", "for the first quarter , our leverage ratio was 4.3 times .", "the fruit preparation business contributed approximately $ 70 million to iff 's nourish segment pro forma sales in 2020 .", "we continued to see healthy performance across our asian markets , achieving a 6 % increase in combined currency - neutral sales , primarily driven by double - digit growth in china and india .", "in latin america , we saw an 11 % increase in overall sales for the region with growth primarily driven by local currency sales .", "covid -19 and related ongoing restrictions continue to heavily impact western and central europe , which has resulted in challenges across the entire emea region and a 5 % decline in overall sales .", "our largest group , nourish , achieved combined currency - neutral sales growth of 1 % , led by robust performance in flavors .", "scent continued its strong performance , achieving combined currency - neutral sales growth of 5 % , the largest growth driver across our four divisions , led by continued strengths in consumer fragrances , double - digit growth in cosmetic actives , and a strong rebound in fine fragrance .", "for our pharma solutions division , we achieved combined currency - neutral sales growth of 3 % , with continued strong performance across the entire division and all sub-categories .", "for health & bioscience division , combined currency - neutral sales decreased 3 % against a strong double - digit year - ago comparison .", "on the revenue synergies front , we have a robust pipeline of projects , including both cross-selling and integrated solutions , that we expect will accelerate our ability to meet our $ 20 million synergy target this year .", "we are confident in our ability to meet our three - year run rate synergy target of $ 400 million .", "we expect these cost savings to increase over the course of the year , putting us well on track to meet our $ 45 million cost synergy target in the full year 2021 , and our year three run rate cost synergy target of $ 300 million .", "in the first quarter , iff generated $ 2.5 billion in sales , a 3 % combined year - over - year increase , including foreign exchange benefits , or up 1 % on a currency - neutral basis , primarily led by strong performances in our scent and pharma solutions divisions .", "meanwhile , our aggressive cost management program led by headcounts and other expense reductions , enabled us to improve rsa to sales by 120 basis points and deliver year - on - year adjusted operating ebitda growth of 4 % .", "as an aside , q1 2020 was our most difficult comp with 7 % combined currency - neutral sales growth and strong adjusted operating ebitda growth .", "iff also delivered adjusted earnings per share , excluding amortization of $ 1.60 for the first quarter .", "nourish sales totaled $ 1.3 billion for the quarter , representing 1 % growth on a combined currency - neutral basis .", "adjusted operating ebitda grew 6 % , with a 60 basis point margin expansion led by strong cost management .", "as andreas noted , h&b had a combined currency - neutral sales decline of 3 % , but this was against a robust 11 % positive year - over - year comparison .", "it should be noted that on the two - year average basis , currency neutral growth was solid at 4 % .", "adjusted operating ebitda was also pressured and operating margin declined by 70 basis points , primarily driven by lower segment volumes and higher raw material and logistics costs .", "microbial control & grain processing were also impacted by continued pre-covid cycling , which impacted h&b 's overall growth by approximately 5 percentage points .", "our scent division generated $ 569 million in total sales , representing 5 % combined currency - neutral growth against a strong 7 % growth in the year - ago period as well .", "on a two - year basis , growth is exceptional at approximately 6 % .", "adjusted operating ebitda improved 8 % with a 70 basis point margin expansion predominantly driven by volume growth across the entire segment , as well as favorable mix from fine fragrance recovery and continued productivity .", "pharma solutions delivered $ 162 million in net sales , representing 3 % in combined currency - neutral growth while adjusted operating ebitda grew 2 % .", "taken in the context of the 11 % growth in the prior - year period , growth is impressive on a two - year basis -- average basis at approximately 7 % .", "as you will see , our operating cash flow was very strong at $ 358 million .", "a large part of our q1 success came from core working capital , where we generated $ 193 million , a great job by our global team and a great outcome .", "in the first quarter , capex was approximately $ 93 million or 3.5 % of sales , up from last q1's combined comparative $ 76 million or 2.6 % of sales .", "free cash flow generation was , therefore , strong $ 265 million , and we distributed $ 82 million in dividends to our shareholders .", "our leverage , which is net debt divided by credit adjusted ebitda ended at 4.3 times , as andreas noted back on slide 6 .", "this is ahead of our expectation of 4.5 times first quarter post - merger leverage .", "legacy iff generated $ 520 million of free cash flow in 2020 and combined , we expect to generate $ 1 billion in 2021 .", "in 2021 , we will invest more in legacy n&b production capacity to meet expected strong future demand , but will only be slightly above our original full - year capex projection of approximately 4.5 % of sales .", "the dividend payment this year will be -- this quarter will be $ 197 million reflecting our higher post - merger share count .", "and we remain on track to meet our long - term deleveraging target of 3 times net debt to credit adjusted ebitda in 24 months to 36 months from deal close .", "on a combined basis , iff generated $ 10.6 billion of revenue for the full year 2020 , with currency neutral growth of approximately 2 % .", "and our combined adjusted operating ebitda margin for 2020 was approximately 22 % .", "please remember that combined includes 11 months of n&b and 12 months of iff in 2020 and 2021 .", "in our fourth quarter conference call in february , we gave initial pro forma guidance , which assume the full 12 months of iff and n&b , in order to be directly comparable to our previously provided s - 4 .", "moving forward , to be more aligned with actual results and reporting , we are transitioning to guiding on 11 months of n&b , which excludes january and 12 months of iff in the 2021 year , in light of the merger completing on feb .", "also , please note that in january 2021 , n&b 's actual sales were approximately $ 507 million and adjusted operating ebitda was $ 107 million .", "we have , therefore , increased our sales expectation for 2021 to be approximately $ 11.25 billion in combined revenues , or plus 6 % growth with an approximately 23 % adjusted operating ebitda margin .", "we are optimistic that for the full second quarter , revenue growth including currency benefit should be in the high - single - digits range , with an adjusted ebitda margin also around 23 % .", "and the 21.5 % is broadly in line with our early expectations .", "the equivalent for heritage iff on a similar basis for the full - year 2020 was approximately 18.5 % ."], "summary_gold": "q1 adjusted earnings per share $ 1.60 .<q>sees combined fy 2021 ( excluding .<q>n&b jan ) sales about $ 11.25 billion .<q>qtrly adjusted earnings per share excluding amortization $ 1.60 .", "summary_pred": "also because of our change to a fiscal calendar rather than a traditional 4 - 4 - 5 calendar , we have had less -- two days less in first quarter .<q>taken in the context of the 11 % growth in the prior - year period , growth is impressive on a two - year basis -- average basis at approximately 7 % .<q>as you will see , our operating cash flow was very strong at $ 358 million .<q>our adjusted operating ebitda margin improved by 30 basis points , reflecting our team 's diligent execution of our cost management strategy .<q>a large part of our q1 success came from core working capital , where we generated $ 193 million , a great job by our global team and a great outcome .<q>for health & bioscience division , combined currency - neutral sales decreased 3 % against a strong double - digit year - ago comparison .<q>for the first quarter , our leverage ratio was 4.3 times .<q>and we remain on track to meet our long - term deleveraging target of 3 times net debt to credit adjusted ebitda in 24 months to 36 months from deal close .<q>the dividend payment this year will be -- this quarter will be $ 197 million reflecting our higher post - merger share count .<q>the fruit preparation business contributed approximately $ 70 million to iff 's nourish segment pro forma sales in 2020 .<q>on a combined basis , iff generated $ 10.6 billion of revenue for the full year 2020 , with currency neutral growth of approximately 2 % .<q>in 2021 , we will invest more in legacy n&b production capacity to meet expected strong future demand , but will only be slightly above our original full - year capex projection of approximately 4.5 % of sales .<q>free cash flow generation was , therefore , strong $ 265 million , and we distributed $ 82 million in dividends to our shareholders .<q>please remember that combined includes 11 months of n&b and 12 months of iff in 2020 and 2021 .<q>in latin america , we saw an 11 % increase in overall sales for the region with growth primarily driven by local currency sales .<q>and the 21.5 % is broadly in line with our early expectations .", "len_article": 52, "len_summary_gold": 4, "len_summary_pred": 16, "len_sent_scores": 52}